The molecular basis of pluripotency in mouse embryonic stem cells

Cloning and Stem Cells

Volumn 6, Issue 4, 2004, Pages 386-391

  Chambers, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HOMEODOMAIN PROTEIN; INTRINSIC FACTOR; LEUKEMIA INHIBITORY FACTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; CELL DIFFERENTIATION; CONFERENCE PAPER; EMBRYO; EMBRYO CELL; GENE EXPRESSION; GENETIC MODEL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALIA;

EID: 11144314914     PISSN: 15362302     EISSN: None     Source Type: Journal    
DOI: 10.1089/clo.2004.6.386     Document Type: Conference Paper

References (38)

1. Ambrosetti, D.C., Scholar, H.R., Dailey, L., et al. (2000). Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J. Biol. Chem. 275, 23387-23397.
2. Avilion, A.A., Nicolis, S.K., Pevny, L.H., et al. (2003). Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140.
3. Bradley, A., Evans, M.J., Kaufman, M.H., et al. (1984). Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-256.
4. Brook, F.A., and Gardner, R.L. (1997). The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA 94, 5709-5712.
5. Burdon, T., Chambers, I., Niwa, H., et al. (1999). Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs 165, 131-143.
6. Chambers, I., Colby, D., Robertson, M., et al. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
7. Chambers, I., and Smith, A. (2004). Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23, 7150-7160.
8. Dodge, J.E., Kang, Y.K., Beppu, H., et al. (2004). Histone H3-K9 methyltransferase ESET is essential for early development. Mol. Cell Biol. 24, 2478-2486.
9. Evans, M.J., and Kaufman, M.H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156.
10. Fujikura, J., Yamato, E., Yonemura, S., et al. (2002). Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev. 16, 784-789.
11. Harland, R. (2000). Neural induction. Curr. Opin. Genet. Dev. 10, 357-362.
12. Heinrich, P.C., Behrmann, I., Haan, S., et al. (2003). Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem. J. 374, 1-20.
13. Kimura, H., Tada, M., Nakatsuji, N., et al. (2004). Histone code modifications on pluripotential nuclei of reprogramed somatic cells. Mol. Cell Biol. 24, 5710-5720.
14. Lovell-Badge, R. (2001). The future for stem cell research. Nature 414, 88-91.
15. Martin, G.R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634-7638.
16. Matsuda, T., Nakamura, T., Nakao, K., et al. (1999). STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. Embo J. 18, 4261-4269.
17. Mitsui, K., Tokuzawa, Y., Itoh, H., et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642.
18. Nichols, J., Zevnik, B., Anastassiadis, K., et al. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391.
19. Niwa, H. (2001). Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct. Funct. 26, 137-148.
20. Niwa, H., Burdon, T., Chambers, I., et al. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060.
21. Niwa, H., Miyazaki, J., and Smith, A.G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376.
22. Norton, J.D. (2000). ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell. Sci. 113, 3897-3905.
23. O'Carroll, D., Erhardt, S., Pagani, M., et al. (2001). The polycomb-group gene Ezh2 is required for early mouse development. Mol. Cell Biol. 21, 4330-4336.
24. O'Looney, B. (1859). Tir na n'Og. The Land of Youth. Translation edited from "Laoi Oisin i dTir na nOg" [The lay of Oisin in the land of youth], M. Comyn, 1750. Trans. Ossianic Soc. 4, 227-280.
25. Pevny, L.H., and Lovell-Badge, R. (1997). Sox genes find their feet. Curr. Opin. Genet. Dev. 7, 338-344.
26. Remenyi, A., Lins, K., Nissen, L.J., et al. (2003). Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev. 17, 2048-2059.
27. Ruzinova, M.B., and Benezra, R. (2003). Id proteins in development, cell cycle and cancer. Trends Cell. Biol. 13, 410-418.
28. Saijoh, Y., Fukii, H., Meno, C., et al. (1996). Identification of putative downstream genes of Oct-3, a pluripotent cell-specific transcription factor. Genes Cells 1, 239-252.
29. Scholer, H.R., Ciesiolka, T., and Gruss, P. (1991). A nexus between Oct-4 and E1A: Implications for gene regulation in embryonic stem cells. Cell 66, 291-304.
30. Smith, A. (1998). Cell therapy: in search of pluripotency. Curr. Biol. 8, 802-804.
31. Smith, A.G., Heath, J.K., Donaldson, D.D., et al. (1988). Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688-690.
32. Stewart, C.L., Kaspar, P., Brunet, L.J., et al. (1992). Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359, 76-79.
33. Tada, M., Takahama, Y., Abe, K., et al. (2001). Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11, 1553-1558.
34. Tokuzawa, Y., Kaiho, E., Maruyama, M., et al. (2003). Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell. Biol. 23, 2699-2708.
35. Vernallis, A.B., Hudson, K.R., and Heath, J.K. (1997). An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M. J. Biol. Chem. 272, 26947-26952.
36. Williams, B.C., Jr., Cai, M., and Clore, G.M. (2004). Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1.Sox2.Hoxb1-DNA ternary transcription factor complex. J. Biol. Chem. 279, 1449-1457.
37. Williams, R.L., Hilton, D.J., Pease, S., et al. (1988). Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687.
38. Ying, Q.L., Nichols, J., Chambers, I., et al. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292.